Breakthrough T1d (Formerly Known as Jdrf Intl.)
Based in DC
🤖
AI Overview
With $6.5M in lobbying spend across 33 quarterly filings, Breakthrough T1d (Formerly Known as Jdrf Intl.) is one of the biggest lobbying spenders in Washington. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$6.5M
Total Spend
8
Years Active
1
Firms Hired
9
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $1.2M |
| 2019 | $1.3M |
| 2020 | $430K |
| 2021 | $230K |
| 2022 | $340K |
| 2023 | $1.2M |
| 2024 | $820K |
| 2025 | $940K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Taxation, Small Business
- •Issues related to the use of smart technology in collaboration with devices for the management
- •of type 1 diabetes (T1D).
- •Issues related to drug pricing, specifically as it relates to Insulin.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.